Diagnosing lung diseases such as COPD, asthma and lung cancer has always been challenging. But new technologies have changed this path.
One important development is portable digital spirometers that, when connected to a smartphone, allow lung function monitoring at home.
By analyzing the volume and speed of airflow, these devices can detect small changes in respiratory function and send early warnings.
In addition, artificial intelligence-based imaging has also been revolutionary. Deep learning algorithms can detect small abnormalities in lung CT scans.
These technologies play a vital role, especially in screening for lung cancer in its early stages, and can save thousands of lives.
Targeted therapies are also being personalized for each patient, with the help of genetic data and precise imaging.
In advanced clinics, telemedicine systems have been set up for remote consultations with lung specialists, increasing patient accessibility.
Wearable sensors have also been developed to monitor blood oxygen levels, heart rate, and breathing patterns in chronic patients.
This data is sent to the doctor in real time, allowing for rapid intervention in the event of a decline in respiratory function.
Overall, the future of lung disease diagnosis is built on data, artificial intelligence, and real-time communications—a new path that simultaneously improves accuracy, speed, and safety.